Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
Eric F. Morand, Edward M Vital, Michelle Petri, Ronald van Vollenhoven, Daniel J. Wallace, Marta Mosca, Richard Furie, Maria Silk, Christina Dickson, Gabriella Meszaros, Bochao Jia, Brenda Crowe, Inmaculada de la Torre, Thomas Dörner
Topics & Concepts
MedicinePlaceboRheumatoid arthritisClinical endpointInternal medicinePopulationLupus erythematosusSystemic lupus erythematosusClinical trialImmunologyDiseaseAntibodyEnvironmental healthPathologyAlternative medicineRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchSpondyloarthritis Studies and Treatments